Healthcare system distrust as driver of gray market adoption
Discussed in 1 analyzed podcast episode across 1 show
Discussed On
Episodes
Science Quickly · May 8, 2026
Influencers are obsessed with peptides. What does the science say?
Peptide chemistry and amino acid building blocksGLP-1 drugs (semaglutide, tirzepatide) and GLP-3 (retatrutide) clinical developmentGray market peptide sourcing and supply chain transparencyCompounding pharmacy regulation and FDA oversightTelehealth distribution networks (Ro, Hims, Hers) and GLP-1 access
View Analysis